Universidade Federal de São Paulo (UNIFESP) Medical Departament of Endocrinology and MetabolismUniversidade do Estado do Rio de Janeiro Biomedical Center Laboratory for Clinical and Experimental Research on Vascular BiologyBrazilian Health Ministry Endocrinology Sector Hospital Federal da LagoaUNIFESP, Medical Departament of Endocrinology and MetabolismSciEL

Clapauch, Ruth

Pardini, Dolores

Arquivos Brasileiros de Endocrinologia & Metabologia

Dolores Pardini

Ruth Clapauch

Crossref

Female endocrinology ? What is it about?

Repositório Institucional UNIFESP

Copyright© ABE&M todos os direitos reservados.89 Arq Bras Endocrinol Metab. 2014;58/2editorialFemale endocrinology – What is it about?Endocrinologia feminina – Do que se trata?Dolores Pardini1, Ruth Clapauch2T his edition of the Brazilian Archives of Endocrinology and Metabolism is dedi-cated to Female Endocrinology, a branch of Endocrinology committed to the study of hormonal regulation of the female reproductive system and its disturbances, from birth to old age. As women represent half of the world population, it is not surprising that Female Endocrinology is so popular among health professionals and women themselves. Female Endocrinology is a scientific department of the Brazilian Society of En-docrinology (SBEM), together with Andrology (DEFA). The editors of the present issue are all past or current DEFA presidents: RC (2001-2002 and 2003-2004); PMS (2009-2010), and DPP is the present president (2013-2014). In this edition, an article on how endocrine disruptors may affect female genital tract development (1) opens the discussion on environmental influences on our bod-ies. Rachel Carlson, who observed reproductive impairment and thus death of birds exposed to pesticides, first described endocrine disruptors in the late 1950s. Nowa-days, we know that many of these compounds are persistent and interfere with the en-docrine system (2), with estrogen receptor agonism as their first and most commonly described action. Bisphenol A (BPA) is a high production volume monomer used in the manufacture of a wide variety of polycarbonate plastics and resins used as dental sealants and as food packaging liners, all of which are formed from polymerization of BPA. The BPA molecule has structural features that are similar to 17β-estradiol and other natural estrogenic compounds found in foods (e.g. daidzein in soy prod-ucts), which give them the ability to bind to estrogen receptors, when present in high enough concentrations.Estrogen-like influences and weight gain may, in part, explain why the age of pu-berty is decreasing to less than 10 years old. In this issue, central precocious puberty is addressed (3) in relation to its etiology, diagnosis, and treatment. Precocious puberty may also be a sign of polycystic ovary syndrome (PCOS). PCOS is a very important chapter of female endocrinology, a disorder of meta-bolic, as well as reproductive function; common (although not universal) co-morbid-ities include insulin resistance, hyperinsulinemia, dyslipidemia, hepatic steatosis, and a predisposition to type 2 diabetes and cardiovascular disease. Sixty percent of patients with PCOS are overweight or obese, and even “normal-weight” subjects have relative visceral adiposity and heightened production of inflammatory adipocytokines (4,5).Hirsutism is another feature of PCOS that represents major discomfort among adolescent and young adults. A brief review on hirsutism diagnosis and treatment is also part of this issue. 1 Medical Departament of Endocrinology and Metabolism, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil2 Laboratory for Clinical and Experimental Research on Vascular Biology (BioVasc), Biomedical Center, Universidade do Estado do Rio de Janeiro (UERJ); and Hospital Federal da Lagoa, Endocrinology Sector, Brazilian Health Ministry, Rio de Janeiro, RJ, BrazilCorrespondence to:Dolores PardiniRua Júpiter 160, ap. 11101532-030 – São Paulo, SP, Brazildpardini@uol.com.brReceived on Oct/14/2013Accepted on Oct/14/2013http://dx.doi.org/10.1590/0004-2730000003060Copyright© ABE&M todos os direitos reservados.90  Arq Bras Endocrinol Metab. 2014;58/2Prolactin disorders may represent a problem in this context, and they are fully addressed in this issue as well. Moving into the reproductive years, an up-to-date approach on how to assess ovulation in fertility-seeking women and how to discover if an endocrine disorder is affecting fertility is shown in this issue. This is ba-sic knowledge for the endocrinologist who whishes to follow his patients up, and assist them in their re-productive needs. Traditionally, reduced fertility and pregnancy rates have been reported in women with classic CAH. Fertility rates of 60-80% and 7-60% have been reported in women with classic SV and classic SW CAH, respectively. In contrast to reduced fertility in classic CAH, pregnancies are commonly normal and uneventful. Thus, fertility, rather than pregnancy rates, seems to be reduced compared with the general popu-lation. Subfertility in females with classic CAH is due to several contributing factors, including androgen excess, adrenal progesterone hypersecretion, consequences of genital reconstructive surgery, secondary polycystic ovaries syndrome, ovarian adrenal rest tumors, and psy-chosexual factors (6).In this edition, we also approach hormonal therapy in transsexual people in this issue. The rationale for medical assessment of transsexual patient lies in the fact that this population is at high risk of suicide, self-mutilation, and depression due to lack of healthcare support. Moreover, the real positive effect of hormone therapy on transsexuals quality of life has been demon-strated (7).REFERENCES1. Teeguarden JG, Hanson-Drury S. A systematic review of Bisphenol A ‘‘low dose’’ studies in the context of human exposure: a case for establishing standards for reporting ‘‘low-dose’’ effects of chemicals. Food Chem Toxicol. 2013;62:935-48.2. Fontenele EG, Martins MR, Quidute AR, Montenegro RM Jr. [Environmental  contaminants and endocrine disruptors]. Arq Bras Endocrinol Metabol. 2010;54(1):6-16.3. Chauhan A, Grissom M. Disorders of childhood growth and development: precocious puberty. FP Essent. 2013;410:25-31.4. Freemark M. Management of adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96(11):3354-6.5. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219-31.6. Mouna FM, Mahdi K, Mohamed A. Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Indian J Endocrinol Metab. 2013;17(5):790-3.7. Bruck JC. [The social background of male to female transsexuals]. Handchir Mikrochir Plast Chir. 2013;45(4):202-6. Female endocrinology

Endocrinologia feminina ? Do que se trata?

http://repositorio.unifesp.br/handle/11600/8285

Endocrinologia feminina ? Do que se trata?

Abstract

Similar works

Full text

Available Versions

Crossref

Repositório Institucional UNIFESP